Clinical outcomes of IDH2...

Clinical outcomes of IDH2 ‐mutated advanced‐phase Ph‐negative myeloproliferative neoplasms treated with enasidenib

Patel, Anand A., Cahill, Kirk, Charnot‐Katsikas, Angella, Liu, Hongtao, Gurbuxani, Sandeep, Thirman, Michael, Kosuri, Satyajit, Artz, Andrew S., Larson, Richard A., Stock, Wendy, Segal, Jeremy, Oden
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
190
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.16709
Date:
July, 2020
File:
PDF, 254 KB
2020
Conversion to is in progress
Conversion to is failed